COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Article view: 202

Article download: 112

Indian Journal of Pathology and Oncology

Evaluation of stromal CD10 expression and its correlation with other clinico-pathological factors in invasive breast carcinoma

Full Text PDF Share on Facebook Share on Twitter

Research Article

Author Details : Maria Kamal, Roobina Khan*, Syed Harris Hasan, Veena Maheshwari

Volume : 6, Issue : 3, Year : 2019

Article Page : 417-421

Suggest article by email


Context: Breast cancer is the most common cause of cancer related deaths among women worldwide, thus forming a significant burden of disease. Various epithelial markers like ER, PR, and Her2/neu are well established factors predicting prognosis and treatment response in breast cancer. However, stroma has a definite role in tumor invasion and metastasis. Novel stromal markers are now emerging which aid in assessing the prognosis and treatment of invasive breast lesions.
Objectives: The present study aims to assess the frequency of stromal CD10 expression in malignant breast lesions and evaluate its prognostic significance and correlation with other clinico-pathological factors.
Design: Of the 172 cases of breast carcinoma, 158 were that of infiltrating ductal carcinoma (NOS) and were selected for CD10 staining forming the study group. Stromal CD10 was assessed immunohistochemically in these breast lesions and statistically correlated with known prognostic markers of breast carcinoma.
Results: Stromal CD10 significantly correlated with increasing tumor grade (P=0.0026), nodal positivity (P=0.0016), ER negativity (P=0.0007), Her2/neu positivity (P=0.0061), and worsening prognosis (P=0.04). No correlation was found between stromal CD10 expression with age, increasing tumor size and tumor stage. A higher CD10 positivity was seen in the triple negative group as compared to the non-triple negative group, but was statistically insignificant (P=0.0994).
Conclusion: Stromal CD10 expression showed a positive correlation with well-known poor prognostic factors in breast cancer [higher tumor grade, nodal positivity, ER negativity, Her2/neu positivity and worsening prognosis (NPI)], suggesting its definite role on tumor aggressiveness and its potential use as an independent prognostic marker.

Keywords: Breast cancer, CD10; Stroma, Prognosis.

Doi : 10.18231/j.ijpo.2019.080

How to cite : Kamal M, Khan R , Hasan S H, Maheshwari V, Evaluation of stromal CD10 expression and its correlation with other clinico-pathological factors in invasive breast carcinoma. Indian J Pathol Oncol 2019;6(3):417-421

Copyright © 2019 by author(s) and Indian J Pathol Oncol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (